INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 59 filers reported holding INSTIL BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $116 | -22.7% | 272 | 0.0% | 0.00% | – |
Q2 2023 | $150 | -16.7% | 272 | 0.0% | 0.00% | – |
Q1 2023 | $180 | – | 272 | 0.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 272 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 272 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -66.7% | 272 | -1.4% | 0.00% | – |
Q1 2022 | $3,000 | -40.0% | 276 | +1.5% | 0.00% | – |
Q4 2021 | $5,000 | 0.0% | 272 | 0.0% | 0.00% | – |
Q3 2021 | $5,000 | – | 272 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Curative Ventures V LLC | 37,980,073 | $16,255,471 | 100.00% |
CPMG Inc | 8,218,467 | $3,517,504 | 1.92% |
Western Standard LLC | 1,796,987 | $769,110 | 0.70% |
Vivo Capital, LLC | 12,486,787 | $5,344,345 | 0.59% |
Nantahala Capital Management | 1,000,000 | $428,000 | 0.04% |
Baker Brothers Advisors | 4,704,395 | $2,013,481 | 0.01% |
HCR Wealth Advisors | 40,000 | $17,120 | 0.00% |
Hennion & Walsh Asset Management, Inc. | 98,080 | $41,978 | 0.00% |
Long Focus Capital Management, LLC | 100,000 | $42,800 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 867,279 | $371,195 | 0.00% |